We serve Chemical Name:1,2:3,5-DI-O-ISOPROPYLIDENE-α-D-APIOSE CAS:25904-06-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,2:3,5-DI-O-ISOPROPYLIDENE-α-D-APIOSE
CAS.NO:25904-06-7
Synonyms:1,2:5,6-DI-O-ISOPROPYLIDENE-A-D-APIOSE;1,2:3,5-di-O-isopropylidene-A-D-apiose;1,2:3,5-Di-O-isopropylidene
Molecular Formula:C11H18O5
Molecular Weight:230.25800
HS Code:
Physical and Chemical Properties:
Melting point:82ºC
Boiling point:278.2ºC at 760 mmHg
Density:1.22g/cm3
Index of Refraction:1.502
PSA:46.15000
Exact Mass:230.11500
LogP:1.01590
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 1,2:5,6-DI-O-ISOPROPYLIDENE-A-D-APIOSE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2:3,5-Di-O-isopropylidene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2:3,5-di-O-isopropylidene-A-D-apiose Use and application,1,2:3,5-Di-O-isopropylidene technical grade,usp/ep/jp grade.
Related News: Expedite biocatalysis development by partnering with an API CDMO 1H-Inden-1-one, 2,3-dihydro-4-(octyloxy)- manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. L-Leucine, L-threonyl-L-valyl-L-prolyl-L-methionyl-L-arginyl-L-seryl- suppliers Besides McNamara’s hire, GSK said it’s expected to name a chair for the OTC firm later this year, who will then establish the board. 5-[[4-[bis(2-chloroethyl)amino]phenyl]iminomethyl]-3,6-bis(dimethylamino)acridine-4-carbaldehyde vendor & factory The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. ,The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts.
